Formation of oligomers by G protein-coupled receptors

Current Opinion in Drug Discovery and Development

Volumn 5, Issue 5, 2002, Pages 756-763

  Gazi, Lucien ^a   López Giménez, Juan F ^a   Strange, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

G protein coupled receptors; Hetero oligomer; Homo oligomer; Ligand binding; Receptor trafficking; Signaling

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BRADYKININ B2 RECEPTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; DOPAMINE 2 RECEPTOR; ENDOMORPHIN 1; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; GONADORELIN RECEPTOR; LEUCINE ENKEPHALIN; MU OPIATE RECEPTOR AGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; OPIATE RECEPTOR; PROTIRELIN RECEPTOR; RACLOPRIDE; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN RECEPTOR; SOMATOSTATIN RECEPTOR; SPIPERONE; TRITIUM; UNINDEXED DRUG;

BIOLUMINESCENCE; ENERGY TRANSFER; FLUORESCENCE; HUMAN; LIGAND BINDING; NEUROTRANSMISSION; OLIGOMERIZATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOPHYSICS; GTP-BINDING PROTEINS; HUMANS; OLIGOPEPTIDES; RECEPTORS, DRUG; SIGNAL TRANSDUCTION;

EID: 0036771040     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Kenakin T: Pharmacological Analysis of Drug-Receptor Interaction. Lippincott-Raven Press, Philadelphia, PA/New York, NY, USA (1997).
2. Angers S, Salahpour A, Bouvier M: DIMERIZATION: An emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol (2002) 42:409-435. •• An exhaustive and comprehensive review that gives an update of the GPCR oligomerization concept. Readers will find interesting information on diverse receptors, including work from the authors' laboratory.
3. Salahpour A, Angers S, Bouvier M: Functional significance of oligomerization of G-protein-coupled receptors. Trends Endocrinol Metab (2000) 11:163-168.
4. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem (1996) 271:16384-16392.
5. Romano C, Yang WL, O'Malley KL: Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem (1996) 271:28612-28616.
6. 3+ - and XL665-derivatized antibodies as FRET partners to analyze GPCR oligomerization using time-resolved FRET.
7. Zeng FY, Wess J: Identification and molecular characterization of m, muscarinic receptor dimers. J Biol Chem (1999) 274:19487-19497.
8. Bai M, Trivedi S, Brown EM: Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem (1998) 273:23605-23610.
9. Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M, McAllister G, Guest PC: Oligomerization of G-protein -coupled receptors shown by selective co-immunoprecipitation. J Biol Chem (2002) 277:15482-15485.
10. B-receptor subtypes assemble into functional heteromeric complexes. Nature (1998) 396:683-687.
11. BR2. Nature (1998) 396:674-679.
12. BR2 is a requisite for their function.
13. Jordan BA, Devi LA: G-protein-coupled receptor heterodimerization modulates receptor function. Nature (1999) 399:697-700.
14. 2A. J Biol Chem (2001) 276:14027-14036.
15. AbdAlla S, Lother H, Quitterer U: AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature (2000) 407:94-98.
16. 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA (2001) 98:343-348.
17. Maggio R, Vogel Z, Wess J: Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA (1993) 90:3103-3107.
18. Bai M,Trivedi S, Kifor O, Quinn SJ, Brown EM: Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci USA (1999) 96:2834-2839.
19. Monnot C, Bihoreau C, Conchon S, Cumow KM, Corvol P, Clauser E: Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expreseion of two deficient mutants. J Biol Chem (1996) 271:1507-1513.
20. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC: Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem (2000) 275:7862-7869.
21. 3 receptors. Mol Pharmacol (2000) 58:677-683.
22. 2 receptor function. Biochemistry (1998) 37:15773-15784.
23. 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA (2000) 97:3684-3689.
24. Kroeger KM, Hanyaloglu AC, Seeber RM, Miles LE, Eidne KA: Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J Biol Chem (2001) 276:12736-12743.
25. 2R, suggesting that this increase is more likely due to conformational changes than an increase in receptor oligomerization. The paper also describes the first possibility of distinguishing between monomer, dimer and higher order oligomers.
26. Overton MC, Blumer KJ: G-protein-coupled receptors function as oligomers in vivo. Curr Biol (2000) 10:341-344.
27. Comea A, Janovick JA, Maya-Nunez G, Conn PM: Gonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. J Biol Chem (2001) 276:2153-2158.
28. Horvat RD, Roess DA, Nelson SE, Barisas BG, Clay CM: Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors. Mol Endocrinol (2001) 15:695-703.
29. 2 receptors by fusion to fluorescent proteins. FEBS Lett (2001) 507:109-113.
30. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC: Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science (2000) 288:154-157.
31. Roess DA, Horvat RD, Munnelly H, Barisas BG: Luteinizing hormone receptors are self-associated in the plasma membrane. Endocrinology (2000) 141:4518-4523. • An interesting example of the use of fluorescence-labeled ligands to monitor receptor oligomerization.
32. Dean MK, Higgs C, Smith RE, Bywater RP, Snell CR, Scott PD, Upton GJ, Howe TJ, Reynolds CA: Dimerization of G-protein-coupled receptors. J Med Chem (2001) 44:4595-4614.
33. Gouldson PR, Snell CR, Bywater RP, Higgs C, Reynolds CA: Domain swapping in G-protein coupled receptor dimers. Protein Eng (1998) 11:1181-1193.
34. Cvejic S, Devi LA: Dimerization of the delta opioid receptor: Implication for a role in receptor internalization. J Biol Chem (1997) 272:26959-26964.
35. Limbird LE, Lefkowitz RJ: Negative cooperativity among β-adrenergic receptors in frog erythrocyte membranes. J Biol Chem (1976) 251:5007-5014.
36. Chidiac P: Rethinking receptor-G protein-effector interactions. Biochem Pharmacol (1998) 55:549-556.
37. Park PS, Sum CS, Pawagi AB, Wells JW: Cooperativity and oligomeric status of cardiac muscarinic cholinergic receptors. Biochemistry (2002) 41:5588-5604. •• An excellent example of very detailed and carefully controlled ligand binding studies, combined with mathematical modeling, leading to conclusions of oligomerization of this GPCR.
38. 2 receptor dimer formation: Evidence from ligand binding. J Biol Chem (2001) 276:22621-22629.
39. 3H]raclopride to rat and human brain membranes. J Neurochem (1990) 55:2048-2057.
40. Martin NA, Prather PL: Interaction of co-expressed μ- and δ-opioid receptors in transfected rat pituitary GH, cells. Mol Pharmacol (2001) 59:774-783.
41. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA: Heterodimerization of μ and δ opioid receptors: A role in opiate synergy. J Neurosci (2000) 20:RC110.
42. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF: Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem (2000) 275:26128-26135.
43. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, Martinez AC: Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J (2001) 20:2497-2507.
44. B receptor function. EMBO J (2001) 20:2152-2159.
45. 3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem (2001) 276:30308-30314.
46. He L, Fong J, von Zastrow M, Whistler JL: Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell (2002) 108:271-282. •• The study proposes that homo-oligomerization of opioid receptors alters the endocytosis of the receptor, resulting in a reduction of tolerance to morphine. This may provide an important new means for the treatment of chronic pain without induction of tolerance.
47. Singer II, Scott S, Kawka DW, Chin J, Daugherty BL, DeMartino JA, DiSalvo J, Gould SL, Lineberger JE, Malkowitz L, Miller MD, Mitnaul L, Siciliano SJ, Staruch MJ, Williams HR, Zweerink HJ, Springer MS: CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 75:3779-3790.
48. Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, Rani A, Hazlett T, Patel SC, Gratton E, Patel YC: Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci USA (2002) 99:3294-3299.
49. Ramsay D, Kellett E, McVey M, Rees S, Milligan G: Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): Hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J (2002) 365:429-440.
50. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT: Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by CCR5Δ32. J Biol Chem (1997) 272:30603-30606.